Pathophysiology and management of renovascular hypertension
Renovascular hypertension is one of the essential cases of secondary arterial hypertension, accounting for about 1-5% of all hypertensive cases. Despite a relatively low prevalence, 10-45% cases with this type of hypertension develop severe hypertension, which is resistant to standard antihypertensi...
Saved in:
Main Author: | Łukasz Dobrek (Author) |
---|---|
Format: | Book |
Published: |
Polish Pharmaceutical Society,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Symptomatology, pathophysiology and treatment perspectives of "long COVID" syndrome
by: Łukasz Dobrek
Published: (2024) -
Antiphosphlipid Syndrome Presented with Renovascular Hypertension
by: Savas Ozturk, et al.
Published: (2016) -
Hypertension crisis as the first symptom of renovascular hypertension in children
by: Lingling Xu, et al.
Published: (2022) -
Long-Term Outcomes of Pediatric Renovascular Hypertension
by: Hyun Chung, et al.
Published: (2017) -
Oxidative stress, the capo of endothelial dysfunction in chronic renovascular hypertension
by: Jung Tak Park, et al.
Published: (2014)